Michael T. Sweeney
Chief Tech/Sci/R&D Officer at RESVERLOGIX CORP.
Net worth: 6 523 $ as of 2024-04-29
Michael T. Sweeney active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RESVERLOGIX CORP. | Chief Tech/Sci/R&D Officer | 2014-11-02 | - |
Career history of Michael T. Sweeney
Former positions of Michael T. Sweeney
| Companies | Position | Start | End |
|---|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Chief Tech/Sci/R&D Officer | 2009-05-05 | 2013-12-31 |
| Corporate Officer/Principal | 2007-11-30 | 2009-05-05 | |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Chief Tech/Sci/R&D Officer | 2003-07-31 | 2007-08-31 |
| PFIZER, INC. | Corporate Officer/Principal | 1994-12-31 | 2002-12-31 |
Zeneca Group Plc
 Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK. | Corporate Officer/Principal | - | - |
Training of Michael T. Sweeney
| The University of Liverpool | Doctorate Degree |
| The University of Manchester | Undergraduate Degree |
| University of London | Graduate Degree |
Statistics
International
| United States | 4 |
| United Kingdom | 4 |
| Canada | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| RESVERLOGIX CORP. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 3 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Zeneca Group Plc
Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK. | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
- Stock Market
- Insiders
- Michael T. Sweeney
- Experience
